Headquartered in Oxnard, California, CURE Pharmaceutical (OTC:CURR) is a fully integrated specialty bioscience company with proprietary dosage forms and delivery systems, the CureFilm™ platform. CureFilm™ can be applied to a broad range of molecules to improve drug efficacy, safety and the patient experience. Our product development programs targets new chemical entities and marketed drugs from traditional pharmaceutical actives to emerging cannabinoid molecules for which our delivery systems can offer unique strategic advantages.
At CURE, we are committed to commercializing innovative therapies that address significant clinical unmet needs. We are more than a technology partner. We understand our partner's business needs and work collaboratively to provide sustainable solutions to patients and stakeholders across the healthcare system.
Cure was founded with the goal of changing the way in which quality medicines are delivered to people in need, regardless of geography or economic status. We operate on the principle of social purpose by extending our focus beyond our products and services to maximize our impact on the world. With this founding principle, we founded Oak Therapeutics, a subsidiary of Cure focused on bringing life-saving medicines to developing economies.